nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—kidney cancer—sarcoma	0.214	0.509	CtDrD
Paclitaxel—lung cancer—sarcoma	0.207	0.491	CtDrD
Paclitaxel—TUBB6—Vincristine—sarcoma	0.0267	0.0642	CbGbCtD
Paclitaxel—TUBB8—Vincristine—sarcoma	0.0267	0.0642	CbGbCtD
Paclitaxel—TUBB2B—Vincristine—sarcoma	0.0267	0.0642	CbGbCtD
Paclitaxel—TUBB2A—Vincristine—sarcoma	0.0267	0.0642	CbGbCtD
Paclitaxel—TUBB3—Vincristine—sarcoma	0.0267	0.0642	CbGbCtD
Paclitaxel—TUBB4A—Vincristine—sarcoma	0.0267	0.0642	CbGbCtD
Paclitaxel—TUBB4B—Vincristine—sarcoma	0.0223	0.0537	CbGbCtD
Paclitaxel—TUBB1—Vincristine—sarcoma	0.0223	0.0537	CbGbCtD
Paclitaxel—TUBB—Vincristine—sarcoma	0.0223	0.0537	CbGbCtD
Paclitaxel—ABCC10—Vincristine—sarcoma	0.017	0.041	CbGbCtD
Paclitaxel—ABCC10—Etoposide—sarcoma	0.0156	0.0376	CbGbCtD
Paclitaxel—CYP1B1—Mitoxantrone—sarcoma	0.0135	0.0324	CbGbCtD
Paclitaxel—ABCC1—Dactinomycin—sarcoma	0.0107	0.0257	CbGbCtD
Paclitaxel—ABCC10—Doxorubicin—sarcoma	0.0106	0.0256	CbGbCtD
Paclitaxel—ABCC1—Mitoxantrone—sarcoma	0.00956	0.023	CbGbCtD
Paclitaxel—ABCB11—Vincristine—sarcoma	0.00926	0.0223	CbGbCtD
Paclitaxel—ABCC1—Epirubicin—sarcoma	0.00774	0.0186	CbGbCtD
Paclitaxel—ABCG2—Dactinomycin—sarcoma	0.00715	0.0172	CbGbCtD
Paclitaxel—ABCC1—Vincristine—sarcoma	0.00658	0.0158	CbGbCtD
Paclitaxel—ABCG2—Mitoxantrone—sarcoma	0.0064	0.0154	CbGbCtD
Paclitaxel—ABCC1—Etoposide—sarcoma	0.00603	0.0145	CbGbCtD
Paclitaxel—CYP1B1—Doxorubicin—sarcoma	0.00579	0.0139	CbGbCtD
Paclitaxel—ABCB11—Doxorubicin—sarcoma	0.00579	0.0139	CbGbCtD
Paclitaxel—ABCC2—Vincristine—sarcoma	0.00487	0.0117	CbGbCtD
Paclitaxel—ABCC2—Etoposide—sarcoma	0.00446	0.0107	CbGbCtD
Paclitaxel—ABCG2—Vincristine—sarcoma	0.0044	0.0106	CbGbCtD
Paclitaxel—ABCC1—Doxorubicin—sarcoma	0.00411	0.00989	CbGbCtD
Paclitaxel—ABCG2—Etoposide—sarcoma	0.00403	0.00971	CbGbCtD
Paclitaxel—CYP3A7—Vincristine—sarcoma	0.00325	0.00782	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.00325	0.00782	CbGbCtD
Paclitaxel—CYP3A4—Thiotepa—sarcoma	0.00321	0.00774	CbGbCtD
Paclitaxel—ABCC2—Doxorubicin—sarcoma	0.00304	0.00732	CbGbCtD
Paclitaxel—ABCG2—Doxorubicin—sarcoma	0.00275	0.00662	CbGbCtD
Paclitaxel—ABCB1—Dactinomycin—sarcoma	0.00258	0.0062	CbGbCtD
Paclitaxel—CYP3A5—Vincristine—sarcoma	0.00244	0.00587	CbGbCtD
Paclitaxel—ABCB1—Mitoxantrone—sarcoma	0.00231	0.00555	CbGbCtD
Paclitaxel—CYP3A5—Etoposide—sarcoma	0.00223	0.00538	CbGbCtD
Paclitaxel—CYP2C8—Etoposide—sarcoma	0.00215	0.00517	CbGbCtD
Paclitaxel—ABCB1—Vincristine—sarcoma	0.00159	0.00382	CbGbCtD
Paclitaxel—ABCB1—Etoposide—sarcoma	0.00145	0.0035	CbGbCtD
Paclitaxel—CYP3A4—Mitoxantrone—sarcoma	0.00138	0.00333	CbGbCtD
Paclitaxel—Docetaxel—EGFR—sarcoma	0.00114	1	CrCbGaD
Paclitaxel—ABCB1—Doxorubicin—sarcoma	0.000992	0.00239	CbGbCtD
Paclitaxel—CYP3A4—Vincristine—sarcoma	0.000951	0.00229	CbGbCtD
Paclitaxel—CYP3A4—Etoposide—sarcoma	0.000871	0.0021	CbGbCtD
Paclitaxel—MAP4—mammary gland—sarcoma	0.000754	0.0207	CbGeAlD
Paclitaxel—CYP3A4—Doxorubicin—sarcoma	0.000594	0.00143	CbGbCtD
Paclitaxel—MAP4—embryo—sarcoma	0.000514	0.0141	CbGeAlD
Paclitaxel—TUBB3—hematopoietic system—sarcoma	0.000459	0.0126	CbGeAlD
Paclitaxel—MAP4—hematopoietic system—sarcoma	0.000459	0.0126	CbGeAlD
Paclitaxel—TUBB1—hematopoietic system—sarcoma	0.000449	0.0123	CbGeAlD
Paclitaxel—TUBB3—connective tissue—sarcoma	0.000442	0.0122	CbGeAlD
Paclitaxel—MAP4—connective tissue—sarcoma	0.000442	0.0122	CbGeAlD
Paclitaxel—MAP2—myometrium—sarcoma	0.000421	0.0116	CbGeAlD
Paclitaxel—BCL2—hematopoietic system—sarcoma	0.000417	0.0115	CbGeAlD
Paclitaxel—TUBB6—mammary gland—sarcoma	0.000412	0.0113	CbGeAlD
Paclitaxel—MAP2—embryo—sarcoma	0.000405	0.0111	CbGeAlD
Paclitaxel—BCL2—connective tissue—sarcoma	0.000402	0.011	CbGeAlD
Paclitaxel—MAP4—skin of body—sarcoma	0.000399	0.011	CbGeAlD
Paclitaxel—MAPT—tendon—sarcoma	0.000387	0.0106	CbGeAlD
Paclitaxel—MAP2—seminal vesicle—sarcoma	0.00038	0.0105	CbGeAlD
Paclitaxel—TUBB8—testis—sarcoma	0.000369	0.0101	CbGeAlD
Paclitaxel—BCL2—smooth muscle tissue—sarcoma	0.000368	0.0101	CbGeAlD
Paclitaxel—NR1I2—liver—sarcoma	0.000364	0.00999	CbGeAlD
Paclitaxel—BCL2—skin of body—sarcoma	0.000363	0.00997	CbGeAlD
Paclitaxel—MAP2—hematopoietic system—sarcoma	0.000362	0.00994	CbGeAlD
Paclitaxel—TUBB4B—mammary gland—sarcoma	0.000358	0.00983	CbGeAlD
Paclitaxel—MAP4—uterus—sarcoma	0.000347	0.00953	CbGeAlD
Paclitaxel—TUBB3—lymphoid tissue—sarcoma	0.000323	0.00888	CbGeAlD
Paclitaxel—MAP4—lymphoid tissue—sarcoma	0.000323	0.00888	CbGeAlD
Paclitaxel—MAPT—testis—sarcoma	0.00032	0.0088	CbGeAlD
Paclitaxel—BCL2—uterus—sarcoma	0.000315	0.00867	CbGeAlD
Paclitaxel—TUBB2B—myometrium—sarcoma	0.000315	0.00864	CbGeAlD
Paclitaxel—TUBB4A—embryo—sarcoma	0.000313	0.0086	CbGeAlD
Paclitaxel—MAP4—tendon—sarcoma	0.000304	0.00835	CbGeAlD
Paclitaxel—TUBB—myometrium—sarcoma	0.000298	0.00818	CbGeAlD
Paclitaxel—TUBB2A—myometrium—sarcoma	0.000296	0.00814	CbGeAlD
Paclitaxel—BCL2—lymphoid tissue—sarcoma	0.000294	0.00808	CbGeAlD
Paclitaxel—TUBB6—myometrium—sarcoma	0.000292	0.00803	CbGeAlD
Paclitaxel—TUBB1—bone marrow—sarcoma	0.000288	0.00791	CbGeAlD
Paclitaxel—TUBB2B—seminal vesicle—sarcoma	0.000284	0.00781	CbGeAlD
Paclitaxel—CYP1B1—mammary gland—sarcoma	0.000283	0.00779	CbGeAlD
Paclitaxel—TUBB4A—hematopoietic system—sarcoma	0.000279	0.00768	CbGeAlD
Paclitaxel—MAP2—cardiac atrium—sarcoma	0.000275	0.00755	CbGeAlD
Paclitaxel—TUBB4A—connective tissue—sarcoma	0.000269	0.00739	CbGeAlD
Paclitaxel—TUBB—seminal vesicle—sarcoma	0.000269	0.00739	CbGeAlD
Paclitaxel—BCL2—bone marrow—sarcoma	0.000268	0.00735	CbGeAlD
Paclitaxel—TUBB2A—seminal vesicle—sarcoma	0.000268	0.00735	CbGeAlD
Paclitaxel—TUBB6—seminal vesicle—sarcoma	0.000264	0.00725	CbGeAlD
Paclitaxel—TUBB2B—connective tissue—sarcoma	0.00026	0.00715	CbGeAlD
Paclitaxel—ABCC10—myometrium—sarcoma	0.000256	0.00703	CbGeAlD
Paclitaxel—TUBB2A—hematopoietic system—sarcoma	0.000254	0.00699	CbGeAlD
Paclitaxel—TUBB4B—myometrium—sarcoma	0.000254	0.00698	CbGeAlD
Paclitaxel—MAP4—testis—sarcoma	0.000252	0.00692	CbGeAlD
Paclitaxel—TUBB3—testis—sarcoma	0.000252	0.00692	CbGeAlD
Paclitaxel—TUBB6—hematopoietic system—sarcoma	0.000251	0.00689	CbGeAlD
Paclitaxel—TUBB1—testis—sarcoma	0.000246	0.00676	CbGeAlD
Paclitaxel—TUBB2A—connective tissue—sarcoma	0.000245	0.00673	CbGeAlD
Paclitaxel—TUBB4B—embryo—sarcoma	0.000244	0.00671	CbGeAlD
Paclitaxel—TUBB4A—skin of body—sarcoma	0.000243	0.00668	CbGeAlD
Paclitaxel—MAP2—tendon—sarcoma	0.000239	0.00658	CbGeAlD
Paclitaxel—MAP4—liver—sarcoma	0.000238	0.00654	CbGeAlD
Paclitaxel—MAPT—lymph node—sarcoma	0.000232	0.00638	CbGeAlD
Paclitaxel—ABCC10—seminal vesicle—sarcoma	0.000231	0.00635	CbGeAlD
Paclitaxel—TUBB4B—seminal vesicle—sarcoma	0.000229	0.0063	CbGeAlD
Paclitaxel—BCL2—testis—sarcoma	0.000229	0.00629	CbGeAlD
Paclitaxel—TUBB—smooth muscle tissue—sarcoma	0.000225	0.00619	CbGeAlD
Paclitaxel—TUBB2A—smooth muscle tissue—sarcoma	0.000224	0.00615	CbGeAlD
Paclitaxel—TUBB2A—skin of body—sarcoma	0.000221	0.00607	CbGeAlD
Paclitaxel—TUBB6—smooth muscle tissue—sarcoma	0.000221	0.00607	CbGeAlD
Paclitaxel—ABCC10—hematopoietic system—sarcoma	0.00022	0.00603	CbGeAlD
Paclitaxel—TUBB6—skin of body—sarcoma	0.000218	0.00599	CbGeAlD
Paclitaxel—TUBB4B—hematopoietic system—sarcoma	0.000218	0.00599	CbGeAlD
Paclitaxel—CYP2C8—mammary gland—sarcoma	0.000217	0.00596	CbGeAlD
Paclitaxel—TUBB4A—uterus—sarcoma	0.000211	0.0058	CbGeAlD
Paclitaxel—TUBB4B—connective tissue—sarcoma	0.00021	0.00577	CbGeAlD
Paclitaxel—SLCO1B3—liver—sarcoma	0.000208	0.00572	CbGeAlD
Paclitaxel—TUBB2B—cardiac atrium—sarcoma	0.000205	0.00564	CbGeAlD
Paclitaxel—MAP2—testis—sarcoma	0.000198	0.00545	CbGeAlD
Paclitaxel—TUBB4A—lymphoid tissue—sarcoma	0.000197	0.00541	CbGeAlD
Paclitaxel—TUBB—cardiac atrium—sarcoma	0.000194	0.00533	CbGeAlD
Paclitaxel—TUBB—uterus—sarcoma	0.000193	0.00531	CbGeAlD
Paclitaxel—TUBB2A—cardiac atrium—sarcoma	0.000193	0.00531	CbGeAlD
Paclitaxel—CYP2C9—mammary gland—sarcoma	0.000193	0.0053	CbGeAlD
Paclitaxel—TUBB2A—uterus—sarcoma	0.000192	0.00528	CbGeAlD
Paclitaxel—TUBB4B—smooth muscle tissue—sarcoma	0.000192	0.00528	CbGeAlD
Paclitaxel—TUBB6—cardiac atrium—sarcoma	0.00019	0.00523	CbGeAlD
Paclitaxel—ABCB11—testis—sarcoma	0.00019	0.00522	CbGeAlD
Paclitaxel—TUBB4B—skin of body—sarcoma	0.00019	0.00521	CbGeAlD
Paclitaxel—TUBB6—uterus—sarcoma	0.000189	0.00521	CbGeAlD
Paclitaxel—MAP2—liver—sarcoma	0.000187	0.00515	CbGeAlD
Paclitaxel—TUBB4A—tendon—sarcoma	0.000185	0.00508	CbGeAlD
Paclitaxel—CYP19A1—hematopoietic system—sarcoma	0.000185	0.00507	CbGeAlD
Paclitaxel—MAP4—lymph node—sarcoma	0.000182	0.00501	CbGeAlD
Paclitaxel—ABCC1—myometrium—sarcoma	0.000181	0.00497	CbGeAlD
Paclitaxel—ABCB11—liver—sarcoma	0.00018	0.00494	CbGeAlD
Paclitaxel—TUBB2B—tendon—sarcoma	0.000179	0.00491	CbGeAlD
Paclitaxel—CYP19A1—connective tissue—sarcoma	0.000178	0.00489	CbGeAlD
Paclitaxel—TUBB6—lymphoid tissue—sarcoma	0.000177	0.00485	CbGeAlD
Paclitaxel—CYP3A7—liver—sarcoma	0.000176	0.00483	CbGeAlD
Paclitaxel—CYP1B1—hematopoietic system—sarcoma	0.000173	0.00474	CbGeAlD
Paclitaxel—TUBB—tendon—sarcoma	0.000169	0.00465	CbGeAlD
Paclitaxel—TUBB2A—tendon—sarcoma	0.000168	0.00462	CbGeAlD
Paclitaxel—ABCC10—cardiac atrium—sarcoma	0.000167	0.00458	CbGeAlD
Paclitaxel—CYP1B1—connective tissue—sarcoma	0.000166	0.00457	CbGeAlD
Paclitaxel—TUBB6—tendon—sarcoma	0.000166	0.00456	CbGeAlD
Paclitaxel—ABCC10—uterus—sarcoma	0.000166	0.00456	CbGeAlD
Paclitaxel—BCL2—lymph node—sarcoma	0.000166	0.00456	CbGeAlD
Paclitaxel—TUBB4B—cardiac atrium—sarcoma	0.000166	0.00455	CbGeAlD
Paclitaxel—TUBB4B—uterus—sarcoma	0.000165	0.00452	CbGeAlD
Paclitaxel—TUBB—bone marrow—sarcoma	0.000164	0.0045	CbGeAlD
Paclitaxel—ABCC1—seminal vesicle—sarcoma	0.000163	0.00449	CbGeAlD
Paclitaxel—TUBB2A—bone marrow—sarcoma	0.000163	0.00448	CbGeAlD
Paclitaxel—TUBB6—bone marrow—sarcoma	0.000161	0.00442	CbGeAlD
Paclitaxel—ABCC10—lymphoid tissue—sarcoma	0.000155	0.00425	CbGeAlD
Paclitaxel—TUBB4B—lymphoid tissue—sarcoma	0.000153	0.00422	CbGeAlD
Paclitaxel—TUBB4A—testis—sarcoma	0.000153	0.00421	CbGeAlD
Paclitaxel—CYP1B1—smooth muscle tissue—sarcoma	0.000152	0.00418	CbGeAlD
Paclitaxel—CYP1B1—skin of body—sarcoma	0.00015	0.00412	CbGeAlD
Paclitaxel—ABCG2—myometrium—sarcoma	0.00015	0.00411	CbGeAlD
Paclitaxel—CYP3A7-CYP3A51P—liver—sarcoma	0.000149	0.0041	CbGeAlD
Paclitaxel—TUBB2B—testis—sarcoma	0.000148	0.00407	CbGeAlD
Paclitaxel—ABCC10—tendon—sarcoma	0.000145	0.00399	CbGeAlD
Paclitaxel—TUBB4A—liver—sarcoma	0.000145	0.00398	CbGeAlD
Paclitaxel—TUBB4B—tendon—sarcoma	0.000144	0.00396	CbGeAlD
Paclitaxel—MAP2—lymph node—sarcoma	0.000144	0.00395	CbGeAlD
Paclitaxel—ABCC10—bone marrow—sarcoma	0.000141	0.00387	CbGeAlD
Paclitaxel—TUBB—testis—sarcoma	0.00014	0.00385	CbGeAlD
Paclitaxel—TUBB4B—bone marrow—sarcoma	0.00014	0.00384	CbGeAlD
Paclitaxel—CYP19A1—uterus—sarcoma	0.00014	0.00383	CbGeAlD
Paclitaxel—TUBB2A—testis—sarcoma	0.000139	0.00383	CbGeAlD
Paclitaxel—TUBB6—testis—sarcoma	0.000137	0.00378	CbGeAlD
Paclitaxel—ABCG2—seminal vesicle—sarcoma	0.000135	0.00372	CbGeAlD
Paclitaxel—TUBB—liver—sarcoma	0.000132	0.00364	CbGeAlD
Paclitaxel—CYP2C8—hematopoietic system—sarcoma	0.000132	0.00363	CbGeAlD
Paclitaxel—TUBB2A—liver—sarcoma	0.000132	0.00362	CbGeAlD
Paclitaxel—CYP1B1—uterus—sarcoma	0.00013	0.00358	CbGeAlD
Paclitaxel—TUBB6—liver—sarcoma	0.00013	0.00357	CbGeAlD
Paclitaxel—CYP1B1—lymphoid tissue—sarcoma	0.000122	0.00334	CbGeAlD
Paclitaxel—ABCC10—testis—sarcoma	0.00012	0.00331	CbGeAlD
Paclitaxel—TUBB4B—testis—sarcoma	0.000119	0.00328	CbGeAlD
Paclitaxel—CYP3A5—hematopoietic system—sarcoma	0.000119	0.00328	CbGeAlD
Paclitaxel—ABCC1—cardiac atrium—sarcoma	0.000118	0.00324	CbGeAlD
Paclitaxel—CYP2C9—hematopoietic system—sarcoma	0.000117	0.00323	CbGeAlD
Paclitaxel—ABCC1—uterus—sarcoma	0.000117	0.00322	CbGeAlD
Paclitaxel—ABCC2—tendon—sarcoma	0.000117	0.00321	CbGeAlD
Paclitaxel—CYP1B1—tendon—sarcoma	0.000114	0.00314	CbGeAlD
Paclitaxel—ABCC10—liver—sarcoma	0.000114	0.00313	CbGeAlD
Paclitaxel—TUBB4B—liver—sarcoma	0.000113	0.0031	CbGeAlD
Paclitaxel—TUBB4A—lymph node—sarcoma	0.000111	0.00305	CbGeAlD
Paclitaxel—TUBB2B—lymph node—sarcoma	0.000107	0.00295	CbGeAlD
Paclitaxel—ABCC1—tendon—sarcoma	0.000103	0.00282	CbGeAlD
Paclitaxel—TUBB—lymph node—sarcoma	0.000102	0.00279	CbGeAlD
Paclitaxel—CYP19A1—testis—sarcoma	0.000101	0.00278	CbGeAlD
Paclitaxel—TUBB2A—lymph node—sarcoma	0.000101	0.00278	CbGeAlD
Paclitaxel—TUBB6—lymph node—sarcoma	9.96e-05	0.00274	CbGeAlD
Paclitaxel—ABCG2—uterus—sarcoma	9.71e-05	0.00267	CbGeAlD
Paclitaxel—ABCC2—testis—sarcoma	9.66e-05	0.00265	CbGeAlD
Paclitaxel—CYP19A1—liver—sarcoma	9.57e-05	0.00263	CbGeAlD
Paclitaxel—CYP1B1—testis—sarcoma	9.46e-05	0.0026	CbGeAlD
Paclitaxel—ABCC2—liver—sarcoma	9.13e-05	0.00251	CbGeAlD
Paclitaxel—CYP3A4—hematopoietic system—sarcoma	8.96e-05	0.00246	CbGeAlD
Paclitaxel—CYP1B1—liver—sarcoma	8.95e-05	0.00246	CbGeAlD
Paclitaxel—ABCC10—lymph node—sarcoma	8.72e-05	0.0024	CbGeAlD
Paclitaxel—TUBB4B—lymph node—sarcoma	8.66e-05	0.00238	CbGeAlD
Paclitaxel—ABCC1—testis—sarcoma	8.51e-05	0.00234	CbGeAlD
Paclitaxel—ABCG2—bone marrow—sarcoma	8.24e-05	0.00226	CbGeAlD
Paclitaxel—ABCC1—liver—sarcoma	8.05e-05	0.00221	CbGeAlD
Paclitaxel—ABCB1—myometrium—sarcoma	7.38e-05	0.00203	CbGeAlD
Paclitaxel—CYP19A1—lymph node—sarcoma	7.34e-05	0.00202	CbGeAlD
Paclitaxel—CYP2C8—testis—sarcoma	7.25e-05	0.00199	CbGeAlD
Paclitaxel—ABCB1—embryo—sarcoma	7.1e-05	0.00195	CbGeAlD
Paclitaxel—ABCG2—testis—sarcoma	7.05e-05	0.00194	CbGeAlD
Paclitaxel—ABCC2—lymph node—sarcoma	7e-05	0.00192	CbGeAlD
Paclitaxel—CYP1B1—lymph node—sarcoma	6.86e-05	0.00188	CbGeAlD
Paclitaxel—CYP2C8—liver—sarcoma	6.85e-05	0.00188	CbGeAlD
Paclitaxel—ABCB1—seminal vesicle—sarcoma	6.67e-05	0.00183	CbGeAlD
Paclitaxel—ABCG2—liver—sarcoma	6.66e-05	0.00183	CbGeAlD
Paclitaxel—ABCB1—hematopoietic system—sarcoma	6.34e-05	0.00174	CbGeAlD
Paclitaxel—CYP3A5—liver—sarcoma	6.18e-05	0.0017	CbGeAlD
Paclitaxel—ABCC1—lymph node—sarcoma	6.17e-05	0.0017	CbGeAlD
Paclitaxel—CYP2C9—liver—sarcoma	6.09e-05	0.00167	CbGeAlD
Paclitaxel—ABCG2—lymph node—sarcoma	5.11e-05	0.0014	CbGeAlD
Paclitaxel—ABCB1—uterus—sarcoma	4.79e-05	0.00132	CbGeAlD
Paclitaxel—CYP3A4—liver—sarcoma	4.64e-05	0.00128	CbGeAlD
Paclitaxel—ABCB1—lymphoid tissue—sarcoma	4.46e-05	0.00123	CbGeAlD
Paclitaxel—BCL2—Apoptosis Modulation and Signaling—JUN—sarcoma	4.45e-05	0.00143	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—JUN—sarcoma	4.43e-05	0.00143	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—MDM2—sarcoma	4.43e-05	0.00143	CbGpPWpGaD
Paclitaxel—ABCG2—HIF-1-alpha transcription factor network—CREB1—sarcoma	4.42e-05	0.00142	CbGpPWpGaD
Paclitaxel—BCL2—Corticotropin-releasing hormone—CTNNB1—sarcoma	4.38e-05	0.00141	CbGpPWpGaD
Paclitaxel—BCL2—IL2-mediated signaling events—HRAS—sarcoma	4.27e-05	0.00137	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—NPM1—sarcoma	4.2e-05	0.00135	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	4.18e-05	0.00135	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—SRC—sarcoma	4.18e-05	0.00135	CbGpPWpGaD
Paclitaxel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	4.17e-05	0.00134	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—CREB1—sarcoma	4.13e-05	0.00133	CbGpPWpGaD
Paclitaxel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	4.11e-05	0.00132	CbGpPWpGaD
Paclitaxel—BCL2—C-MYB transcription factor network—NRAS—sarcoma	4.09e-05	0.00132	CbGpPWpGaD
Paclitaxel—BCL2—Direct p53 effectors—MMP2—sarcoma	4.08e-05	0.00131	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	4.07e-05	0.00131	CbGpPWpGaD
Paclitaxel—ABCB1—bone marrow—sarcoma	4.06e-05	0.00112	CbGeAlD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—NRAS—sarcoma	4.02e-05	0.00129	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	4.01e-05	0.00129	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	4e-05	0.00129	CbGpPWpGaD
Paclitaxel—BCL2—Kit receptor signaling pathway—HRAS—sarcoma	3.97e-05	0.00128	CbGpPWpGaD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—JUN—sarcoma	3.97e-05	0.00128	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	3.97e-05	0.00128	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—KDR—sarcoma	3.92e-05	0.00126	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—CCND1—sarcoma	3.86e-05	0.00124	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—JUN—sarcoma	3.85e-05	0.00124	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—NPM1—sarcoma	3.84e-05	0.00124	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—NRAS—sarcoma	3.82e-05	0.00123	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—CTNNB1—sarcoma	3.82e-05	0.00123	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—MYC—sarcoma	3.81e-05	0.00123	CbGpPWpGaD
Paclitaxel—BCL2—C-MYB transcription factor network—MYC—sarcoma	3.81e-05	0.00123	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—MYC—sarcoma	3.75e-05	0.00121	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—sarcoma	3.66e-05	0.00118	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	3.66e-05	0.00118	CbGpPWpGaD
Paclitaxel—ABCG2—Fluoropyrimidine Activity—TP53—sarcoma	3.65e-05	0.00118	CbGpPWpGaD
Paclitaxel—BCL2—Direct p53 effectors—MDM2—sarcoma	3.63e-05	0.00117	CbGpPWpGaD
Paclitaxel—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	3.62e-05	0.00117	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	3.59e-05	0.00116	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—FOXO1—sarcoma	3.58e-05	0.00115	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—MYC—sarcoma	3.56e-05	0.00115	CbGpPWpGaD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—SRC—sarcoma	3.56e-05	0.00115	CbGpPWpGaD
Paclitaxel—BCL2—C-MYB transcription factor network—KRAS—sarcoma	3.52e-05	0.00113	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	3.49e-05	0.00113	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—EGFR—sarcoma	3.48e-05	0.00112	CbGpPWpGaD
Paclitaxel—ABCB1—testis—sarcoma	3.47e-05	0.000955	CbGeAlD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—KRAS—sarcoma	3.46e-05	0.00111	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	3.42e-05	0.0011	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—MDM2—sarcoma	3.41e-05	0.0011	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—NRAS—sarcoma	3.32e-05	0.00107	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—KRAS—sarcoma	3.29e-05	0.00106	CbGpPWpGaD
Paclitaxel—ABCB1—liver—sarcoma	3.28e-05	0.000903	CbGeAlD
Paclitaxel—Bronchitis—Doxorubicin—sarcoma	3.25e-05	0.000343	CcSEcCtD
Paclitaxel—Dermatitis—Thiotepa—sarcoma	3.25e-05	0.000343	CcSEcCtD
Paclitaxel—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	3.24e-05	0.00104	CbGpPWpGaD
Paclitaxel—Headache—Thiotepa—sarcoma	3.23e-05	0.000341	CcSEcCtD
Paclitaxel—Stevens-Johnson syndrome—Epirubicin—sarcoma	3.23e-05	0.000341	CcSEcCtD
Paclitaxel—Rash—Dactinomycin—sarcoma	3.23e-05	0.000341	CcSEcCtD
Paclitaxel—Decreased appetite—Etoposide—sarcoma	3.22e-05	0.00034	CcSEcCtD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	3.21e-05	0.00104	CbGpPWpGaD
Paclitaxel—Pancytopenia—Doxorubicin—sarcoma	3.21e-05	0.000339	CcSEcCtD
Paclitaxel—Renal failure—Epirubicin—sarcoma	3.2e-05	0.000338	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Etoposide—sarcoma	3.2e-05	0.000338	CcSEcCtD
Paclitaxel—Asthenia—Mitoxantrone—sarcoma	3.2e-05	0.000337	CcSEcCtD
Paclitaxel—Fatigue—Etoposide—sarcoma	3.2e-05	0.000337	CcSEcCtD
Paclitaxel—Neuropathy peripheral—Epirubicin—sarcoma	3.19e-05	0.000337	CcSEcCtD
Paclitaxel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	3.18e-05	0.00103	CbGpPWpGaD
Paclitaxel—ABCG2—HIF-1-alpha transcription factor network—JUN—sarcoma	3.18e-05	0.00102	CbGpPWpGaD
Paclitaxel—Stomatitis—Epirubicin—sarcoma	3.17e-05	0.000335	CcSEcCtD
Paclitaxel—Constipation—Etoposide—sarcoma	3.17e-05	0.000334	CcSEcCtD
Paclitaxel—Pain—Etoposide—sarcoma	3.17e-05	0.000334	CcSEcCtD
Paclitaxel—Conjunctivitis—Epirubicin—sarcoma	3.17e-05	0.000334	CcSEcCtD
Paclitaxel—Urinary tract infection—Epirubicin—sarcoma	3.17e-05	0.000334	CcSEcCtD
Paclitaxel—MAPT—BDNF signaling pathway—HRAS—sarcoma	3.16e-05	0.00102	CbGpPWpGaD
Paclitaxel—Dysuria—Doxorubicin—sarcoma	3.16e-05	0.000334	CcSEcCtD
Paclitaxel—Neutropenia—Doxorubicin—sarcoma	3.16e-05	0.000334	CcSEcCtD
Paclitaxel—BCL2—Direct p53 effectors—JUN—sarcoma	3.15e-05	0.00102	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	3.14e-05	0.00101	CbGpPWpGaD
Paclitaxel—Upper respiratory tract infection—Doxorubicin—sarcoma	3.14e-05	0.000331	CcSEcCtD
Paclitaxel—BCL2—Apoptosis—TP53—sarcoma	3.13e-05	0.00101	CbGpPWpGaD
Paclitaxel—Diarrhoea—Vincristine—sarcoma	3.13e-05	0.00033	CcSEcCtD
Paclitaxel—Pollakiuria—Doxorubicin—sarcoma	3.12e-05	0.000329	CcSEcCtD
Paclitaxel—MAPT—Apoptosis—TP53—sarcoma	3.12e-05	0.001	CbGpPWpGaD
Paclitaxel—Haematuria—Epirubicin—sarcoma	3.11e-05	0.000328	CcSEcCtD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—MYC—sarcoma	3.1e-05	0.000997	CbGpPWpGaD
Paclitaxel—Photosensitivity reaction—Doxorubicin—sarcoma	3.09e-05	0.000326	CcSEcCtD
Paclitaxel—Hepatobiliary disease—Epirubicin—sarcoma	3.08e-05	0.000325	CcSEcCtD
Paclitaxel—Weight increased—Doxorubicin—sarcoma	3.08e-05	0.000325	CcSEcCtD
Paclitaxel—Epistaxis—Epirubicin—sarcoma	3.07e-05	0.000324	CcSEcCtD
Paclitaxel—Nausea—Thiotepa—sarcoma	3.06e-05	0.000323	CcSEcCtD
Paclitaxel—Weight decreased—Doxorubicin—sarcoma	3.06e-05	0.000323	CcSEcCtD
Paclitaxel—Sinusitis—Epirubicin—sarcoma	3.06e-05	0.000322	CcSEcCtD
Paclitaxel—Feeling abnormal—Etoposide—sarcoma	3.05e-05	0.000322	CcSEcCtD
Paclitaxel—Hyperglycaemia—Doxorubicin—sarcoma	3.05e-05	0.000322	CcSEcCtD
Paclitaxel—Diarrhoea—Mitoxantrone—sarcoma	3.05e-05	0.000322	CcSEcCtD
Paclitaxel—Nausea—Dactinomycin—sarcoma	3.04e-05	0.000321	CcSEcCtD
Paclitaxel—Pneumonia—Doxorubicin—sarcoma	3.03e-05	0.00032	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Etoposide—sarcoma	3.03e-05	0.00032	CcSEcCtD
Paclitaxel—Dizziness—Vincristine—sarcoma	3.03e-05	0.000319	CcSEcCtD
Paclitaxel—Infestation—Doxorubicin—sarcoma	3.01e-05	0.000318	CcSEcCtD
Paclitaxel—Infestation NOS—Doxorubicin—sarcoma	3.01e-05	0.000318	CcSEcCtD
Paclitaxel—BCL2—C-MYB transcription factor network—HRAS—sarcoma	3e-05	0.000965	CbGpPWpGaD
Paclitaxel—Stevens-Johnson syndrome—Doxorubicin—sarcoma	2.99e-05	0.000315	CcSEcCtD
Paclitaxel—Bradycardia—Epirubicin—sarcoma	2.98e-05	0.000314	CcSEcCtD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—CCND1—sarcoma	2.97e-05	0.000958	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	2.97e-05	0.000956	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—JUN—sarcoma	2.97e-05	0.000956	CbGpPWpGaD
Paclitaxel—Renal failure—Doxorubicin—sarcoma	2.96e-05	0.000313	CcSEcCtD
Paclitaxel—Neuropathy peripheral—Doxorubicin—sarcoma	2.95e-05	0.000312	CcSEcCtD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	2.95e-05	0.000948	CbGpPWpGaD
Paclitaxel—Urticaria—Etoposide—sarcoma	2.94e-05	0.000311	CcSEcCtD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—sarcoma	2.94e-05	0.000947	CbGpPWpGaD
Paclitaxel—Haemoglobin—Epirubicin—sarcoma	2.94e-05	0.00031	CcSEcCtD
Paclitaxel—BCL2—Apoptosis Modulation and Signaling—TP53—sarcoma	2.94e-05	0.000946	CbGpPWpGaD
Paclitaxel—Stomatitis—Doxorubicin—sarcoma	2.94e-05	0.00031	CcSEcCtD
Paclitaxel—Rhinitis—Epirubicin—sarcoma	2.93e-05	0.000309	CcSEcCtD
Paclitaxel—Body temperature increased—Etoposide—sarcoma	2.93e-05	0.000309	CcSEcCtD
Paclitaxel—Abdominal pain—Etoposide—sarcoma	2.93e-05	0.000309	CcSEcCtD
Paclitaxel—Conjunctivitis—Doxorubicin—sarcoma	2.93e-05	0.000309	CcSEcCtD
Paclitaxel—Urinary tract infection—Doxorubicin—sarcoma	2.93e-05	0.000309	CcSEcCtD
Paclitaxel—MAPT—MAPK Signaling Pathway—TP53—sarcoma	2.93e-05	0.000942	CbGpPWpGaD
Paclitaxel—Haemorrhage—Epirubicin—sarcoma	2.92e-05	0.000309	CcSEcCtD
Paclitaxel—Hypoaesthesia—Epirubicin—sarcoma	2.91e-05	0.000307	CcSEcCtD
Paclitaxel—Vomiting—Vincristine—sarcoma	2.91e-05	0.000307	CcSEcCtD
Paclitaxel—Pharyngitis—Epirubicin—sarcoma	2.9e-05	0.000306	CcSEcCtD
Paclitaxel—Urinary tract disorder—Epirubicin—sarcoma	2.89e-05	0.000305	CcSEcCtD
Paclitaxel—Rash—Vincristine—sarcoma	2.88e-05	0.000304	CcSEcCtD
Paclitaxel—BCL2—Apoptosis—CTNNB1—sarcoma	2.88e-05	0.000929	CbGpPWpGaD
Paclitaxel—Dermatitis—Vincristine—sarcoma	2.88e-05	0.000304	CcSEcCtD
Paclitaxel—Oedema peripheral—Epirubicin—sarcoma	2.88e-05	0.000304	CcSEcCtD
Paclitaxel—Haematuria—Doxorubicin—sarcoma	2.87e-05	0.000303	CcSEcCtD
Paclitaxel—Connective tissue disorder—Epirubicin—sarcoma	2.87e-05	0.000303	CcSEcCtD
Paclitaxel—Urethral disorder—Epirubicin—sarcoma	2.87e-05	0.000302	CcSEcCtD
Paclitaxel—Headache—Vincristine—sarcoma	2.87e-05	0.000302	CcSEcCtD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—KRAS—sarcoma	2.86e-05	0.000921	CbGpPWpGaD
Paclitaxel—Hepatobiliary disease—Doxorubicin—sarcoma	2.85e-05	0.000301	CcSEcCtD
Paclitaxel—Epistaxis—Doxorubicin—sarcoma	2.84e-05	0.0003	CcSEcCtD
Paclitaxel—Vomiting—Mitoxantrone—sarcoma	2.83e-05	0.000299	CcSEcCtD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	2.83e-05	0.000911	CbGpPWpGaD
Paclitaxel—Sinusitis—Doxorubicin—sarcoma	2.83e-05	0.000298	CcSEcCtD
Paclitaxel—Visual impairment—Epirubicin—sarcoma	2.82e-05	0.000297	CcSEcCtD
Paclitaxel—Rash—Mitoxantrone—sarcoma	2.81e-05	0.000296	CcSEcCtD
Paclitaxel—Dermatitis—Mitoxantrone—sarcoma	2.81e-05	0.000296	CcSEcCtD
Paclitaxel—ABCB1—Allograft Rejection—PDGFRA—sarcoma	2.8e-05	0.000902	CbGpPWpGaD
Paclitaxel—Headache—Mitoxantrone—sarcoma	2.79e-05	0.000295	CcSEcCtD
Paclitaxel—ABCG2—HIF-1-alpha transcription factor network—VEGFA—sarcoma	2.77e-05	0.000893	CbGpPWpGaD
Paclitaxel—Erythema multiforme—Epirubicin—sarcoma	2.76e-05	0.000292	CcSEcCtD
Paclitaxel—Bradycardia—Doxorubicin—sarcoma	2.75e-05	0.000291	CcSEcCtD
Paclitaxel—BCL2—Innate Immune System—PLCG1—sarcoma	2.74e-05	0.000884	CbGpPWpGaD
Paclitaxel—Eye disorder—Epirubicin—sarcoma	2.73e-05	0.000288	CcSEcCtD
Paclitaxel—Hypersensitivity—Etoposide—sarcoma	2.73e-05	0.000288	CcSEcCtD
Paclitaxel—Tinnitus—Epirubicin—sarcoma	2.73e-05	0.000288	CcSEcCtD
Paclitaxel—Haemoglobin—Doxorubicin—sarcoma	2.72e-05	0.000287	CcSEcCtD
Paclitaxel—Nausea—Vincristine—sarcoma	2.72e-05	0.000287	CcSEcCtD
Paclitaxel—Flushing—Epirubicin—sarcoma	2.71e-05	0.000286	CcSEcCtD
Paclitaxel—Cardiac disorder—Epirubicin—sarcoma	2.71e-05	0.000286	CcSEcCtD
Paclitaxel—Rhinitis—Doxorubicin—sarcoma	2.71e-05	0.000286	CcSEcCtD
Paclitaxel—Haemorrhage—Doxorubicin—sarcoma	2.71e-05	0.000285	CcSEcCtD
Paclitaxel—Hypoaesthesia—Doxorubicin—sarcoma	2.69e-05	0.000284	CcSEcCtD
Paclitaxel—Pharyngitis—Doxorubicin—sarcoma	2.69e-05	0.000283	CcSEcCtD
Paclitaxel—Urinary tract disorder—Doxorubicin—sarcoma	2.67e-05	0.000282	CcSEcCtD
Paclitaxel—Oedema peripheral—Doxorubicin—sarcoma	2.67e-05	0.000281	CcSEcCtD
Paclitaxel—Asthenia—Etoposide—sarcoma	2.66e-05	0.000281	CcSEcCtD
Paclitaxel—Connective tissue disorder—Doxorubicin—sarcoma	2.66e-05	0.000281	CcSEcCtD
Paclitaxel—Angiopathy—Epirubicin—sarcoma	2.65e-05	0.00028	CcSEcCtD
Paclitaxel—Urethral disorder—Doxorubicin—sarcoma	2.65e-05	0.00028	CcSEcCtD
Paclitaxel—Nausea—Mitoxantrone—sarcoma	2.65e-05	0.000279	CcSEcCtD
Paclitaxel—Immune system disorder—Epirubicin—sarcoma	2.64e-05	0.000279	CcSEcCtD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	2.64e-05	0.00085	CbGpPWpGaD
Paclitaxel—Mediastinal disorder—Epirubicin—sarcoma	2.64e-05	0.000278	CcSEcCtD
Paclitaxel—Chills—Epirubicin—sarcoma	2.62e-05	0.000277	CcSEcCtD
Paclitaxel—Pruritus—Etoposide—sarcoma	2.62e-05	0.000277	CcSEcCtD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—TP53—sarcoma	2.62e-05	0.000844	CbGpPWpGaD
Paclitaxel—Arrhythmia—Epirubicin—sarcoma	2.61e-05	0.000276	CcSEcCtD
Paclitaxel—Visual impairment—Doxorubicin—sarcoma	2.61e-05	0.000275	CcSEcCtD
Paclitaxel—BCL2—Innate Immune System—ATF1—sarcoma	2.61e-05	0.000839	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	2.61e-05	0.000839	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—CREB1—sarcoma	2.6e-05	0.000837	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—VEGFA—sarcoma	2.59e-05	0.000835	CbGpPWpGaD
Paclitaxel—Alopecia—Epirubicin—sarcoma	2.58e-05	0.000273	CcSEcCtD
Paclitaxel—Mental disorder—Epirubicin—sarcoma	2.56e-05	0.00027	CcSEcCtD
Paclitaxel—Erythema multiforme—Doxorubicin—sarcoma	2.56e-05	0.00027	CcSEcCtD
Paclitaxel—Erythema—Epirubicin—sarcoma	2.55e-05	0.000269	CcSEcCtD
Paclitaxel—Malnutrition—Epirubicin—sarcoma	2.55e-05	0.000269	CcSEcCtD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—TP53—sarcoma	2.54e-05	0.000819	CbGpPWpGaD
Paclitaxel—Diarrhoea—Etoposide—sarcoma	2.54e-05	0.000268	CcSEcCtD
Paclitaxel—Eye disorder—Doxorubicin—sarcoma	2.53e-05	0.000267	CcSEcCtD
Paclitaxel—Tinnitus—Doxorubicin—sarcoma	2.52e-05	0.000266	CcSEcCtD
Paclitaxel—ABCB1—lymph node—sarcoma	2.52e-05	0.000692	CbGeAlD
Paclitaxel—Cardiac disorder—Doxorubicin—sarcoma	2.51e-05	0.000265	CcSEcCtD
Paclitaxel—Flushing—Doxorubicin—sarcoma	2.51e-05	0.000265	CcSEcCtD
Paclitaxel—Flatulence—Epirubicin—sarcoma	2.51e-05	0.000265	CcSEcCtD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—HRAS—sarcoma	2.51e-05	0.000807	CbGpPWpGaD
Paclitaxel—Tension—Epirubicin—sarcoma	2.5e-05	0.000264	CcSEcCtD
Paclitaxel—Dysgeusia—Epirubicin—sarcoma	2.49e-05	0.000263	CcSEcCtD
Paclitaxel—BCL2—Direct p53 effectors—EGFR—sarcoma	2.48e-05	0.000798	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—CCND1—sarcoma	2.47e-05	0.000797	CbGpPWpGaD
Paclitaxel—Nervousness—Epirubicin—sarcoma	2.47e-05	0.000261	CcSEcCtD
Paclitaxel—BCL2—Focal Adhesion—JUN—sarcoma	2.47e-05	0.000795	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	2.46e-05	0.000794	CbGpPWpGaD
Paclitaxel—Back pain—Epirubicin—sarcoma	2.46e-05	0.00026	CcSEcCtD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	2.46e-05	0.000792	CbGpPWpGaD
Paclitaxel—Angiopathy—Doxorubicin—sarcoma	2.45e-05	0.000259	CcSEcCtD
Paclitaxel—BCL2—Focal Adhesion—CTNNB1—sarcoma	2.45e-05	0.000789	CbGpPWpGaD
Paclitaxel—Dizziness—Etoposide—sarcoma	2.45e-05	0.000259	CcSEcCtD
Paclitaxel—Muscle spasms—Epirubicin—sarcoma	2.45e-05	0.000258	CcSEcCtD
Paclitaxel—Immune system disorder—Doxorubicin—sarcoma	2.44e-05	0.000258	CcSEcCtD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	2.44e-05	0.000786	CbGpPWpGaD
Paclitaxel—Mediastinal disorder—Doxorubicin—sarcoma	2.44e-05	0.000257	CcSEcCtD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—HRAS—sarcoma	2.43e-05	0.000783	CbGpPWpGaD
Paclitaxel—Chills—Doxorubicin—sarcoma	2.43e-05	0.000256	CcSEcCtD
Paclitaxel—Arrhythmia—Doxorubicin—sarcoma	2.42e-05	0.000255	CcSEcCtD
Paclitaxel—Vision blurred—Epirubicin—sarcoma	2.4e-05	0.000253	CcSEcCtD
Paclitaxel—Alopecia—Doxorubicin—sarcoma	2.39e-05	0.000252	CcSEcCtD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—CREB1—sarcoma	2.39e-05	0.000769	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—MYC—sarcoma	2.39e-05	0.000768	CbGpPWpGaD
Paclitaxel—Mental disorder—Doxorubicin—sarcoma	2.37e-05	0.00025	CcSEcCtD
Paclitaxel—Ill-defined disorder—Epirubicin—sarcoma	2.36e-05	0.000249	CcSEcCtD
Paclitaxel—Vomiting—Etoposide—sarcoma	2.36e-05	0.000249	CcSEcCtD
Paclitaxel—Malnutrition—Doxorubicin—sarcoma	2.36e-05	0.000249	CcSEcCtD
Paclitaxel—Erythema—Doxorubicin—sarcoma	2.36e-05	0.000249	CcSEcCtD
Paclitaxel—Anaemia—Epirubicin—sarcoma	2.35e-05	0.000248	CcSEcCtD
Paclitaxel—Agitation—Epirubicin—sarcoma	2.34e-05	0.000247	CcSEcCtD
Paclitaxel—Rash—Etoposide—sarcoma	2.34e-05	0.000247	CcSEcCtD
Paclitaxel—Dermatitis—Etoposide—sarcoma	2.33e-05	0.000246	CcSEcCtD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—EGFR—sarcoma	2.33e-05	0.000751	CbGpPWpGaD
Paclitaxel—Headache—Etoposide—sarcoma	2.32e-05	0.000245	CcSEcCtD
Paclitaxel—Flatulence—Doxorubicin—sarcoma	2.32e-05	0.000245	CcSEcCtD
Paclitaxel—Tension—Doxorubicin—sarcoma	2.31e-05	0.000244	CcSEcCtD
Paclitaxel—Dysgeusia—Doxorubicin—sarcoma	2.31e-05	0.000243	CcSEcCtD
Paclitaxel—Malaise—Epirubicin—sarcoma	2.3e-05	0.000242	CcSEcCtD
Paclitaxel—Nervousness—Doxorubicin—sarcoma	2.29e-05	0.000241	CcSEcCtD
Paclitaxel—Vertigo—Epirubicin—sarcoma	2.29e-05	0.000241	CcSEcCtD
Paclitaxel—Syncope—Epirubicin—sarcoma	2.28e-05	0.000241	CcSEcCtD
Paclitaxel—Leukopenia—Epirubicin—sarcoma	2.28e-05	0.00024	CcSEcCtD
Paclitaxel—Back pain—Doxorubicin—sarcoma	2.28e-05	0.00024	CcSEcCtD
Paclitaxel—Muscle spasms—Doxorubicin—sarcoma	2.26e-05	0.000239	CcSEcCtD
Paclitaxel—BCL2—Immune System—CD34—sarcoma	2.26e-05	0.000727	CbGpPWpGaD
Paclitaxel—Palpitations—Epirubicin—sarcoma	2.25e-05	0.000237	CcSEcCtD
Paclitaxel—Loss of consciousness—Epirubicin—sarcoma	2.24e-05	0.000236	CcSEcCtD
Paclitaxel—Cough—Epirubicin—sarcoma	2.22e-05	0.000234	CcSEcCtD
Paclitaxel—Vision blurred—Doxorubicin—sarcoma	2.22e-05	0.000234	CcSEcCtD
Paclitaxel—BCL2—Focal Adhesion—SRC—sarcoma	2.22e-05	0.000713	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	2.21e-05	0.00071	CbGpPWpGaD
Paclitaxel—Convulsion—Epirubicin—sarcoma	2.21e-05	0.000233	CcSEcCtD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—KRAS—sarcoma	2.2e-05	0.00071	CbGpPWpGaD
Paclitaxel—Nausea—Etoposide—sarcoma	2.2e-05	0.000232	CcSEcCtD
Paclitaxel—Hypertension—Epirubicin—sarcoma	2.2e-05	0.000232	CcSEcCtD
Paclitaxel—Ill-defined disorder—Doxorubicin—sarcoma	2.19e-05	0.000231	CcSEcCtD
Paclitaxel—Anaemia—Doxorubicin—sarcoma	2.18e-05	0.00023	CcSEcCtD
Paclitaxel—Chest pain—Epirubicin—sarcoma	2.17e-05	0.000229	CcSEcCtD
Paclitaxel—Arthralgia—Epirubicin—sarcoma	2.17e-05	0.000229	CcSEcCtD
Paclitaxel—Myalgia—Epirubicin—sarcoma	2.17e-05	0.000229	CcSEcCtD
Paclitaxel—Agitation—Doxorubicin—sarcoma	2.16e-05	0.000228	CcSEcCtD
Paclitaxel—Anxiety—Epirubicin—sarcoma	2.16e-05	0.000228	CcSEcCtD
Paclitaxel—BCL2—Focal Adhesion—VEGFA—sarcoma	2.16e-05	0.000695	CbGpPWpGaD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	2.15e-05	0.000227	CcSEcCtD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—MDM2—sarcoma	2.15e-05	0.000693	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	2.15e-05	0.000692	CbGpPWpGaD
Paclitaxel—Discomfort—Epirubicin—sarcoma	2.14e-05	0.000226	CcSEcCtD
Paclitaxel—Malaise—Doxorubicin—sarcoma	2.12e-05	0.000224	CcSEcCtD
Paclitaxel—Dry mouth—Epirubicin—sarcoma	2.12e-05	0.000224	CcSEcCtD
Paclitaxel—Vertigo—Doxorubicin—sarcoma	2.12e-05	0.000223	CcSEcCtD
Paclitaxel—Syncope—Doxorubicin—sarcoma	2.11e-05	0.000223	CcSEcCtD
Paclitaxel—Leukopenia—Doxorubicin—sarcoma	2.11e-05	0.000222	CcSEcCtD
Paclitaxel—Confusional state—Epirubicin—sarcoma	2.09e-05	0.000221	CcSEcCtD
Paclitaxel—BCL2—Direct p53 effectors—TP53—sarcoma	2.08e-05	0.00067	CbGpPWpGaD
Paclitaxel—Palpitations—Doxorubicin—sarcoma	2.08e-05	0.00022	CcSEcCtD
Paclitaxel—Anaphylactic shock—Epirubicin—sarcoma	2.08e-05	0.000219	CcSEcCtD
Paclitaxel—Oedema—Epirubicin—sarcoma	2.08e-05	0.000219	CcSEcCtD
Paclitaxel—Loss of consciousness—Doxorubicin—sarcoma	2.07e-05	0.000218	CcSEcCtD
Paclitaxel—Infection—Epirubicin—sarcoma	2.06e-05	0.000218	CcSEcCtD
Paclitaxel—Cough—Doxorubicin—sarcoma	2.06e-05	0.000217	CcSEcCtD
Paclitaxel—Shock—Epirubicin—sarcoma	2.04e-05	0.000216	CcSEcCtD
Paclitaxel—Convulsion—Doxorubicin—sarcoma	2.04e-05	0.000215	CcSEcCtD
Paclitaxel—Nervous system disorder—Epirubicin—sarcoma	2.04e-05	0.000215	CcSEcCtD
Paclitaxel—Thrombocytopenia—Epirubicin—sarcoma	2.03e-05	0.000215	CcSEcCtD
Paclitaxel—Hypertension—Doxorubicin—sarcoma	2.03e-05	0.000215	CcSEcCtD
Paclitaxel—Tachycardia—Epirubicin—sarcoma	2.03e-05	0.000214	CcSEcCtD
Paclitaxel—Skin disorder—Epirubicin—sarcoma	2.02e-05	0.000213	CcSEcCtD
Paclitaxel—Hyperhidrosis—Epirubicin—sarcoma	2.01e-05	0.000212	CcSEcCtD
Paclitaxel—Chest pain—Doxorubicin—sarcoma	2.01e-05	0.000212	CcSEcCtD
Paclitaxel—Myalgia—Doxorubicin—sarcoma	2.01e-05	0.000212	CcSEcCtD
Paclitaxel—Arthralgia—Doxorubicin—sarcoma	2.01e-05	0.000212	CcSEcCtD
Paclitaxel—Anxiety—Doxorubicin—sarcoma	2e-05	0.000211	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	1.99e-05	0.00021	CcSEcCtD
Paclitaxel—Discomfort—Doxorubicin—sarcoma	1.98e-05	0.000209	CcSEcCtD
Paclitaxel—Anorexia—Epirubicin—sarcoma	1.98e-05	0.000209	CcSEcCtD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.98e-05	0.000637	CbGpPWpGaD
Paclitaxel—Dry mouth—Doxorubicin—sarcoma	1.96e-05	0.000207	CcSEcCtD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—TP53—sarcoma	1.96e-05	0.000631	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—FOXO1—sarcoma	1.95e-05	0.000627	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—PDGFRB—sarcoma	1.94e-05	0.000626	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—EGFR—sarcoma	1.94e-05	0.000625	CbGpPWpGaD
Paclitaxel—Hypotension—Epirubicin—sarcoma	1.94e-05	0.000205	CcSEcCtD
Paclitaxel—Confusional state—Doxorubicin—sarcoma	1.94e-05	0.000205	CcSEcCtD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.93e-05	0.000623	CbGpPWpGaD
Paclitaxel—Anaphylactic shock—Doxorubicin—sarcoma	1.92e-05	0.000203	CcSEcCtD
Paclitaxel—Oedema—Doxorubicin—sarcoma	1.92e-05	0.000203	CcSEcCtD
Paclitaxel—BCL2—Apoptosis—TP53—sarcoma	1.92e-05	0.000618	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—PDGFRA—sarcoma	1.91e-05	0.000616	CbGpPWpGaD
Paclitaxel—Infection—Doxorubicin—sarcoma	1.91e-05	0.000201	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Epirubicin—sarcoma	1.89e-05	0.0002	CcSEcCtD
Paclitaxel—Shock—Doxorubicin—sarcoma	1.89e-05	0.0002	CcSEcCtD
Paclitaxel—Nervous system disorder—Doxorubicin—sarcoma	1.88e-05	0.000199	CcSEcCtD
Paclitaxel—Thrombocytopenia—Doxorubicin—sarcoma	1.88e-05	0.000199	CcSEcCtD
Paclitaxel—Insomnia—Epirubicin—sarcoma	1.88e-05	0.000198	CcSEcCtD
Paclitaxel—Tachycardia—Doxorubicin—sarcoma	1.88e-05	0.000198	CcSEcCtD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—CCND1—sarcoma	1.87e-05	0.000603	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—JUN—sarcoma	1.87e-05	0.000602	CbGpPWpGaD
Paclitaxel—Skin disorder—Doxorubicin—sarcoma	1.87e-05	0.000197	CcSEcCtD
Paclitaxel—Paraesthesia—Epirubicin—sarcoma	1.87e-05	0.000197	CcSEcCtD
Paclitaxel—Hyperhidrosis—Doxorubicin—sarcoma	1.86e-05	0.000196	CcSEcCtD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	1.86e-05	0.000597	CbGpPWpGaD
Paclitaxel—Dyspnoea—Epirubicin—sarcoma	1.85e-05	0.000195	CcSEcCtD
Paclitaxel—Somnolence—Epirubicin—sarcoma	1.85e-05	0.000195	CcSEcCtD
Paclitaxel—Anorexia—Doxorubicin—sarcoma	1.83e-05	0.000193	CcSEcCtD
Paclitaxel—Dyspepsia—Epirubicin—sarcoma	1.83e-05	0.000193	CcSEcCtD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.83e-05	0.000588	CbGpPWpGaD
Paclitaxel—Decreased appetite—Epirubicin—sarcoma	1.81e-05	0.000191	CcSEcCtD
Paclitaxel—Hypotension—Doxorubicin—sarcoma	1.8e-05	0.00019	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Epirubicin—sarcoma	1.79e-05	0.000189	CcSEcCtD
Paclitaxel—Fatigue—Epirubicin—sarcoma	1.79e-05	0.000189	CcSEcCtD
Paclitaxel—Pain—Epirubicin—sarcoma	1.78e-05	0.000187	CcSEcCtD
Paclitaxel—Constipation—Epirubicin—sarcoma	1.78e-05	0.000187	CcSEcCtD
Paclitaxel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	1.75e-05	0.000564	CbGpPWpGaD
Paclitaxel—Musculoskeletal discomfort—Doxorubicin—sarcoma	1.75e-05	0.000185	CcSEcCtD
Paclitaxel—Insomnia—Doxorubicin—sarcoma	1.74e-05	0.000183	CcSEcCtD
Paclitaxel—Paraesthesia—Doxorubicin—sarcoma	1.73e-05	0.000182	CcSEcCtD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	1.72e-05	0.000553	CbGpPWpGaD
Paclitaxel—Dyspnoea—Doxorubicin—sarcoma	1.71e-05	0.000181	CcSEcCtD
Paclitaxel—Feeling abnormal—Epirubicin—sarcoma	1.71e-05	0.000181	CcSEcCtD
Paclitaxel—Somnolence—Doxorubicin—sarcoma	1.71e-05	0.00018	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Epirubicin—sarcoma	1.7e-05	0.000179	CcSEcCtD
Paclitaxel—Dyspepsia—Doxorubicin—sarcoma	1.69e-05	0.000179	CcSEcCtD
Paclitaxel—Decreased appetite—Doxorubicin—sarcoma	1.67e-05	0.000176	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Doxorubicin—sarcoma	1.66e-05	0.000175	CcSEcCtD
Paclitaxel—Fatigue—Doxorubicin—sarcoma	1.66e-05	0.000175	CcSEcCtD
Paclitaxel—Urticaria—Epirubicin—sarcoma	1.65e-05	0.000174	CcSEcCtD
Paclitaxel—Constipation—Doxorubicin—sarcoma	1.64e-05	0.000173	CcSEcCtD
Paclitaxel—Pain—Doxorubicin—sarcoma	1.64e-05	0.000173	CcSEcCtD
Paclitaxel—Body temperature increased—Epirubicin—sarcoma	1.64e-05	0.000173	CcSEcCtD
Paclitaxel—Abdominal pain—Epirubicin—sarcoma	1.64e-05	0.000173	CcSEcCtD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—sarcoma	1.63e-05	0.000526	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—PTPRC—sarcoma	1.63e-05	0.000526	CbGpPWpGaD
Paclitaxel—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	1.62e-05	0.000523	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	1.62e-05	0.000523	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—PLCG1—sarcoma	1.6e-05	0.000515	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—MDM2—sarcoma	1.59e-05	0.000511	CbGpPWpGaD
Paclitaxel—Feeling abnormal—Doxorubicin—sarcoma	1.58e-05	0.000167	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Doxorubicin—sarcoma	1.57e-05	0.000166	CcSEcCtD
Paclitaxel—NR1I2—Generic Transcription Pathway—MYC—sarcoma	1.56e-05	0.000503	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—HRAS—sarcoma	1.56e-05	0.000502	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle, Mitotic—CCND1—sarcoma	1.55e-05	0.000498	CbGpPWpGaD
Paclitaxel—Hypersensitivity—Epirubicin—sarcoma	1.53e-05	0.000161	CcSEcCtD
Paclitaxel—ABCB1—Allograft Rejection—IL2—sarcoma	1.53e-05	0.000492	CbGpPWpGaD
Paclitaxel—Urticaria—Doxorubicin—sarcoma	1.53e-05	0.000161	CcSEcCtD
Paclitaxel—Body temperature increased—Doxorubicin—sarcoma	1.52e-05	0.00016	CcSEcCtD
Paclitaxel—Abdominal pain—Doxorubicin—sarcoma	1.52e-05	0.00016	CcSEcCtD
Paclitaxel—BCL2—Immune System—ATF1—sarcoma	1.52e-05	0.000489	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—MYC—sarcoma	1.5e-05	0.000484	CbGpPWpGaD
Paclitaxel—TUBB2B—Metabolism of proteins—MMP2—sarcoma	1.5e-05	0.000484	CbGpPWpGaD
Paclitaxel—TUBB6—Metabolism of proteins—MMP2—sarcoma	1.5e-05	0.000484	CbGpPWpGaD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	1.5e-05	0.000483	CbGpPWpGaD
Paclitaxel—Asthenia—Epirubicin—sarcoma	1.49e-05	0.000157	CcSEcCtD
Paclitaxel—BCL2—Innate Immune System—KIT—sarcoma	1.48e-05	0.000478	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—EGFR—sarcoma	1.47e-05	0.000473	CbGpPWpGaD
Paclitaxel—Pruritus—Epirubicin—sarcoma	1.47e-05	0.000155	CcSEcCtD
Paclitaxel—TUBB3—Metabolism of proteins—MMP2—sarcoma	1.45e-05	0.000467	CbGpPWpGaD
Paclitaxel—Diarrhoea—Epirubicin—sarcoma	1.42e-05	0.00015	CcSEcCtD
Paclitaxel—Hypersensitivity—Doxorubicin—sarcoma	1.42e-05	0.000149	CcSEcCtD
Paclitaxel—BCL2—Innate Immune System—CREB1—sarcoma	1.41e-05	0.000455	CbGpPWpGaD
Paclitaxel—TUBB2A—Metabolism of proteins—MMP2—sarcoma	1.4e-05	0.000452	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—TLE1—sarcoma	1.4e-05	0.00045	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—KRAS—sarcoma	1.39e-05	0.000447	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	1.38e-05	0.000445	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—CCND1—sarcoma	1.38e-05	0.000445	CbGpPWpGaD
Paclitaxel—Asthenia—Doxorubicin—sarcoma	1.38e-05	0.000146	CcSEcCtD
Paclitaxel—Dizziness—Epirubicin—sarcoma	1.37e-05	0.000145	CcSEcCtD
Paclitaxel—TUBB1—Metabolism of proteins—MMP2—sarcoma	1.37e-05	0.000442	CbGpPWpGaD
Paclitaxel—Pruritus—Doxorubicin—sarcoma	1.36e-05	0.000143	CcSEcCtD
Paclitaxel—Vomiting—Epirubicin—sarcoma	1.32e-05	0.000139	CcSEcCtD
Paclitaxel—Diarrhoea—Doxorubicin—sarcoma	1.32e-05	0.000139	CcSEcCtD
Paclitaxel—TUBB4A—Cell Cycle—MDM2—sarcoma	1.31e-05	0.000423	CbGpPWpGaD
Paclitaxel—Rash—Epirubicin—sarcoma	1.31e-05	0.000138	CcSEcCtD
Paclitaxel—Dermatitis—Epirubicin—sarcoma	1.31e-05	0.000138	CcSEcCtD
Paclitaxel—Headache—Epirubicin—sarcoma	1.3e-05	0.000137	CcSEcCtD
Paclitaxel—ABCB1—Allograft Rejection—VEGFA—sarcoma	1.3e-05	0.000418	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—ENO2—sarcoma	1.29e-05	0.000416	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—HBA1—sarcoma	1.28e-05	0.000413	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle, Mitotic—CCND1—sarcoma	1.28e-05	0.000412	CbGpPWpGaD
Paclitaxel—Dizziness—Doxorubicin—sarcoma	1.27e-05	0.000134	CcSEcCtD
Paclitaxel—ABCC1—Disease—NPM1—sarcoma	1.26e-05	0.000405	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle, Mitotic—MYC—sarcoma	1.24e-05	0.000399	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—TP53—sarcoma	1.23e-05	0.000397	CbGpPWpGaD
Paclitaxel—Nausea—Epirubicin—sarcoma	1.23e-05	0.00013	CcSEcCtD
Paclitaxel—TUBB4A—Metabolism of proteins—MMP2—sarcoma	1.23e-05	0.000397	CbGpPWpGaD
Paclitaxel—Vomiting—Doxorubicin—sarcoma	1.22e-05	0.000129	CcSEcCtD
Paclitaxel—ABCB11—Metabolism—ENO2—sarcoma	1.22e-05	0.000392	CbGpPWpGaD
Paclitaxel—Rash—Doxorubicin—sarcoma	1.21e-05	0.000128	CcSEcCtD
Paclitaxel—Dermatitis—Doxorubicin—sarcoma	1.21e-05	0.000128	CcSEcCtD
Paclitaxel—ABCB11—Metabolism—HBA1—sarcoma	1.21e-05	0.000389	CbGpPWpGaD
Paclitaxel—Headache—Doxorubicin—sarcoma	1.2e-05	0.000127	CcSEcCtD
Paclitaxel—TUBB4B—Cell Cycle—MDM2—sarcoma	1.2e-05	0.000387	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle, Mitotic—CCND1—sarcoma	1.17e-05	0.000377	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—MDM2—sarcoma	1.17e-05	0.000376	CbGpPWpGaD
Paclitaxel—TUBB2B—Metabolism of proteins—CTNNB1—sarcoma	1.15e-05	0.000371	CbGpPWpGaD
Paclitaxel—TUBB6—Metabolism of proteins—CTNNB1—sarcoma	1.15e-05	0.000371	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—CCND1—sarcoma	1.15e-05	0.000369	CbGpPWpGaD
Paclitaxel—Nausea—Doxorubicin—sarcoma	1.14e-05	0.00012	CcSEcCtD
Paclitaxel—BCL2—Immune System—FOXO1—sarcoma	1.13e-05	0.000365	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—PDGFRB—sarcoma	1.13e-05	0.000364	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—MMP2—sarcoma	1.13e-05	0.000363	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—PDGFRA—sarcoma	1.11e-05	0.000359	CbGpPWpGaD
Paclitaxel—TUBB3—Metabolism of proteins—CTNNB1—sarcoma	1.11e-05	0.000358	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—MYC—sarcoma	1.11e-05	0.000357	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PLCG1—sarcoma	1.1e-05	0.000353	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—ENO2—sarcoma	1.09e-05	0.000351	CbGpPWpGaD
Paclitaxel—TUBB2A—Metabolism of proteins—CTNNB1—sarcoma	1.08e-05	0.000347	CbGpPWpGaD
Paclitaxel—TUBB1—Metabolism of proteins—CTNNB1—sarcoma	1.05e-05	0.000339	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—CCND1—sarcoma	1.05e-05	0.000337	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PLCG1—sarcoma	1.03e-05	0.000332	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle, Mitotic—MYC—sarcoma	1.03e-05	0.000331	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	1.02e-05	0.000329	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—JUN—sarcoma	1.02e-05	0.000327	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—CTNNB1—sarcoma	1.01e-05	0.000325	CbGpPWpGaD
Paclitaxel—TUBB4A—Metabolism of proteins—CTNNB1—sarcoma	9.45e-06	0.000304	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle, Mitotic—MYC—sarcoma	9.4e-06	0.000303	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PLCG1—sarcoma	9.25e-06	0.000298	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—MYC—sarcoma	9.19e-06	0.000296	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—ENO2—sarcoma	9.17e-06	0.000295	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—ENO2—sarcoma	9.13e-06	0.000294	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—HBA1—sarcoma	9.12e-06	0.000294	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—SRC—sarcoma	9.11e-06	0.000293	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—TP53—sarcoma	9.1e-06	0.000293	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—HBA1—sarcoma	9.08e-06	0.000292	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CXCR4—sarcoma	8.89e-06	0.000286	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—ENO2—sarcoma	8.84e-06	0.000284	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—HBA1—sarcoma	8.78e-06	0.000283	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—NRAS—sarcoma	8.76e-06	0.000282	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—CTNNB1—sarcoma	8.65e-06	0.000278	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—KIT—sarcoma	8.64e-06	0.000278	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	8.44e-06	0.000272	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—MYC—sarcoma	8.4e-06	0.000271	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CREB1—sarcoma	8.22e-06	0.000265	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ENO2—sarcoma	8.04e-06	0.000259	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—HBA1—sarcoma	7.99e-06	0.000257	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—EGFR—sarcoma	7.98e-06	0.000257	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ENO2—sarcoma	7.97e-06	0.000257	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—HBA1—sarcoma	7.92e-06	0.000255	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PLCG1—sarcoma	7.78e-06	0.000251	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PLCG1—sarcoma	7.75e-06	0.00025	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—TP53—sarcoma	7.54e-06	0.000243	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—KRAS—sarcoma	7.54e-06	0.000243	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—MYC—sarcoma	7.51e-06	0.000242	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PLCG1—sarcoma	7.5e-06	0.000241	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	7.35e-06	0.000237	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	7.34e-06	0.000236	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	7.28e-06	0.000235	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—TP53—sarcoma	6.9e-06	0.000222	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PLCG1—sarcoma	6.82e-06	0.00022	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—MDM2—sarcoma	6.8e-06	0.000219	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PLCG1—sarcoma	6.76e-06	0.000218	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	6.58e-06	0.000212	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—FOXO1—sarcoma	6.57e-06	0.000211	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PDGFRB—sarcoma	6.56e-06	0.000211	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PDGFRA—sarcoma	6.45e-06	0.000208	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	6.41e-06	0.000206	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—HRAS—sarcoma	6.41e-06	0.000206	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL2—sarcoma	6.08e-06	0.000196	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—JUN—sarcoma	5.91e-06	0.00019	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	5.9e-06	0.00019	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CTNNB1—sarcoma	5.87e-06	0.000189	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	5.77e-06	0.000186	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ENO2—sarcoma	5.76e-06	0.000185	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—HBA1—sarcoma	5.72e-06	0.000184	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	5.45e-06	0.000176	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—SRC—sarcoma	5.31e-06	0.000171	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—NRAS—sarcoma	5.1e-06	0.000164	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—KIT—sarcoma	5e-06	0.000161	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ENO2—sarcoma	4.99e-06	0.000161	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—HBA1—sarcoma	4.96e-06	0.00016	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PLCG1—sarcoma	4.89e-06	0.000157	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	4.84e-06	0.000156	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CREB1—sarcoma	4.76e-06	0.000153	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—EGFR—sarcoma	4.65e-06	0.00015	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—KRAS—sarcoma	4.39e-06	0.000141	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ENO2—sarcoma	4.35e-06	0.00014	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—HBA1—sarcoma	4.32e-06	0.000139	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PLCG1—sarcoma	4.23e-06	0.000136	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ENO2—sarcoma	4.06e-06	0.000131	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—HBA1—sarcoma	4.03e-06	0.00013	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MDM2—sarcoma	3.94e-06	0.000127	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HRAS—sarcoma	3.73e-06	0.00012	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PLCG1—sarcoma	3.69e-06	0.000119	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PLCG1—sarcoma	3.44e-06	0.000111	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CTNNB1—sarcoma	3.4e-06	0.000109	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—SRC—sarcoma	3.07e-06	9.89e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NRAS—sarcoma	2.96e-06	9.52e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MYC—sarcoma	2.75e-06	8.87e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—EGFR—sarcoma	2.69e-06	8.67e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ENO2—sarcoma	2.68e-06	8.62e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—HBA1—sarcoma	2.66e-06	8.57e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—KRAS—sarcoma	2.54e-06	8.19e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PLCG1—sarcoma	2.27e-06	7.32e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—HRAS—sarcoma	2.16e-06	6.96e-05	CbGpPWpGaD
